Co-Authors
This is a "connection" page, showing publications co-authored by Dezheng Huo and James Dolezal.
Connection Strength
0.454
-
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast Cancer. medRxiv. 2026 May 05.
Score: 0.243
-
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence. medRxiv. 2026 May 12.
Score: 0.061
-
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer. medRxiv. 2025 Aug 27.
Score: 0.058
-
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence. NPJ Breast Cancer. 2023 Apr 14; 9(1):25.
Score: 0.049
-
The impact of site-specific digital histology signatures on deep learning model accuracy and bias. Nat Commun. 2021 07 20; 12(1):4423.
Score: 0.044